iCAD (ICAD) Announces Treatment of First Patient in Europe with Xoft Axxent eBx System
Tweet Send to a Friend
iCAD, Inc. (Nasdaq: ICAD) announced the first cervical cancer patient in Europe was treated with the Xoft Axxent Electronic Brachytherapy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
